- Home
- DBI vs CLPT Comparison
DBI vs CLPT Comparison
Compare DBI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- CLPT
- Stock Information
- Founded
- DBI 1991
- CLPT 1998
- Country
- DBI United States
- CLPT United States
- Employees
- DBI N/A
- CLPT N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- CLPT Medical/Dental Instruments
- Sector
- DBI Consumer Discretionary
- CLPT Health Care
- Exchange
- DBI Nasdaq
- CLPT Nasdaq
- Market Cap
- DBI 292.2M
- CLPT 337.6M
- IPO Year
- DBI 1991
- CLPT N/A
- Fundamental
- Price
- DBI $5.65
- CLPT $15.55
- Analyst Decision
- DBI Hold
- CLPT Strong Buy
- Analyst Count
- DBI 2
- CLPT 2
- Target Price
- DBI $5.75
- CLPT $12.00
- AVG Volume (30 Days)
- DBI 2.3M
- CLPT 243.1K
- Earning Date
- DBI 12-10-2024
- CLPT 11-07-2024
- Dividend Yield
- DBI 3.57%
- CLPT N/A
- EPS Growth
- DBI N/A
- CLPT N/A
- EPS
- DBI N/A
- CLPT N/A
- Revenue
- DBI $3,050,038,000.00
- CLPT $30,429,000.00
- Revenue This Year
- DBI $0.78
- CLPT $35.56
- Revenue Next Year
- DBI $3.19
- CLPT $21.86
- P/E Ratio
- DBI N/A
- CLPT N/A
- Revenue Growth
- DBI N/A
- CLPT 36.34
- 52 Week Low
- DBI $4.36
- CLPT $5.11
- 52 Week High
- DBI $11.57
- CLPT $17.47
- Technical
- Relative Strength Index (RSI)
- DBI 50.89
- CLPT 60.50
- Support Level
- DBI $5.28
- CLPT $15.24
- Resistance Level
- DBI $6.21
- CLPT $16.63
- Average True Range (ATR)
- DBI 0.51
- CLPT 1.19
- MACD
- DBI 0.02
- CLPT 0.08
- Stochastic Oscillator
- DBI 57.05
- CLPT 65.87
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.